Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-6xw6y4wPhase 3Recruiting
Phase 3, randomised, open-label trial of Bronchitol in intracranial hypertension (IH) (2 arms), sponsored by Hospital Universitário Onofre Lopes. Primary endpoint: Change in optic nerve sheath diameter. Started May 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-6xw6y4w.